about
The management of glaucoma and intraocular hypertension: current approaches and recent advancesMeta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertensionApraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleateShould laser trabeculoplasty be the initial mode of treatment in open-angle glaucoma?Effects of long-term treatment with timolol on lacrimal gland functionLatanoprost versus timolol as first choice therapy in patients with ocular hypertension. A cost-effectiveness analysis.Potentially hazardous co-prescribing of beta-adrenoceptor antagonists and agonists in the communityTear analysis in contact lens wearersPharmaceutical management of the childhood glaucomas.Current concepts of pharmacotherapy in hypertension--ophthalmically administered beta blockers and their cardiopulmonary effects.An evaluation of the fixed-combination of latanoprost and timolol for use in open-angle glaucoma and ocular hypertension.Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleateLong-term evaluation of timolol.Changing therapeutic paradigms in glaucoma management.Chronic open-angle glaucoma. Review for primary care physicians.Evolving paradigms in the medical treatment of glaucoma.Pharmacogenetics of ophthalmic topical beta-blockers.Effect of topical ketanserin administration on intraocular pressureMedical treatment of glaucoma--a reappraisal of the risks.Betaxolol.Preoperative timolol and ocular compression in cataract surgery.Effect of timolol with and without preservative on the basal tear turnover in glaucomaEye drops--the hidden poison.Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%).Allergic contact conjunctivitis due to timolol in eyedrops.The influence of long-term treatment with timolol on human tear lysozyme albumin content.Betaxolol eye drops. A clinical trial of safety and efficacy.Beta-blockers in the treatment of chronic simple glaucoma.Effect of preserved and preservative-free timolol eye drops on tear film stability in healthy AfricansAntiglaucoma medication and clinical depression.Timolol side effects and inadvertent overdosing.Brimonidine .2% as a replacement for beta blockers in geriatric patients with glaucoma.A comparison of betaxolol and timolol in open angle glaucoma and ocular hypertension.The efficacy of bimatoprost 0.03% monotherapy in patients previously using topical beta-blocker monotherapy for the treatment of glaucoma or ocular hypertension.Corneal anaesthesia after topical treatment with timolol maleate. A case report.Glaucoma-Intraocular Pressure Reduction.Timolol-maintenance treatment.Glaucoma: systemic side effects of topical medical therapy--a common and under recognized problem.[Changes in lung function following administration of eyedrops containing timolol, metipranolol, pindolol and pilocarpine in healthy probands and patients with mild bronchial asthma].
P2860
Q22305849-A71FFF7A-6C8B-4F81-9A41-24E2A5735028Q24672885-F7CA6850-280B-4E3E-B1AB-9FE813324711Q28334547-DA8BF52F-F2BE-44EC-8DAE-22A853BB202CQ30661692-37AC9245-9F1C-4C0E-AB56-EC5D023E8356Q33641357-0D77142F-E54C-4EC1-B10D-B187D443FD6EQ33669278-EFCEA80A-CD93-4972-9852-5E01B8B8813AQ34054974-1CCBCAA5-F7ED-4FEA-83A8-01F5A165D69DQ34164909-7E3D90AB-DEA2-446E-8C23-4061B2CB5DCCQ34182084-0D436EC6-C74E-4683-8454-7816CDA33431Q34287845-BF88436B-6775-461A-80BA-47D524FB32DAQ35753429-C3C56261-6B4A-424B-81C7-0289B2AC6BE6Q35919192-33AADBA1-5EAB-4B8E-9520-6263549F8821Q35919813-C1D24C90-CA94-427F-9F7B-BCCEA9B97288Q36181220-2DD9FA29-2691-4902-B6AA-3867253ECB9FQ36270877-F5098DEB-E954-48FD-9350-4645D677299BQ36419282-EB5BE031-6E69-4F7F-BED0-9AD49044E4A4Q37116485-8A63765E-C23F-45D4-8CB3-126C4BEFD723Q37301474-D35F5E19-2CBB-4780-B170-179291489C1BQ37317865-35D90D9A-F37E-4155-BE54-F7FD4A5683D9Q38362560-0C52CB2D-ACD3-4D15-AF09-6FD365BDC413Q39353381-94DCFEFB-AE06-480E-B1A1-2D70B8C0DCFDQ39708297-FAD2D3C7-48E3-482E-BEC7-A656829C04BDQ41168997-3AFE5E43-B83F-46BD-B92A-C477BD2E8E9BQ41352665-D68AFD22-312E-4CA7-B186-42FB66F27AA0Q42019630-39FF9811-18C1-47A8-A6CB-33F89F58377FQ42263717-DC3B617C-65CF-46A8-994B-24D5CCE0BE2EQ42277133-B4735068-1CA6-422C-B70E-49787D5BE85DQ42334091-E96C6AFA-7A17-4848-9CEC-909947ABC6C1Q42777455-9D3D2E41-F6D9-4364-AE5B-9D62151D8B4DQ43733460-2E3D1503-179E-4377-ADB9-97B3ACCF1EC2Q43906942-499DDF7A-E0D5-4DEA-A08F-65EEB8B029D9Q44031260-E3EBAA12-4F48-455F-BBFA-80DDBE23C3D4Q45069510-65C3C67F-C644-4C22-9EAF-EDAE856C70ADQ46459864-606D2153-E0B6-4E86-8996-F142DD74A343Q51867222-F12A2C5E-8E2C-4603-A746-88FCAC6738A2Q53555670-8D08634A-0DE3-4D6B-9CD2-42E46A81AFA6Q53697382-D7CE7D7E-B9FE-4438-8B1D-6B9ED919659EQ54022632-5681A13C-173F-41E6-8C5F-A4948482F5C7Q54399973-672D9D64-212C-49FB-97A3-9D5BA208FF05
P2860
description
1979 nî lūn-bûn
@nan
1979 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Adverse effects experienced by patients taking timolol
@ast
Adverse effects experienced by patients taking timolol
@en
Adverse effects experienced by patients taking timolol
@nl
type
label
Adverse effects experienced by patients taking timolol
@ast
Adverse effects experienced by patients taking timolol
@en
Adverse effects experienced by patients taking timolol
@nl
prefLabel
Adverse effects experienced by patients taking timolol
@ast
Adverse effects experienced by patients taking timolol
@en
Adverse effects experienced by patients taking timolol
@nl
P2093
P1476
Adverse effects experienced by patients taking timolol
@en
P2093
C D McMahon
H D Hoskins
J Hetherington
R N Shaffer
P356
10.1016/0002-9394(79)90674-3
P407
P577
1979-10-01T00:00:00Z